Compare DRD & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRD | ITGR |
|---|---|---|
| Founded | 1895 | 1970 |
| Country | South Africa | United States |
| Employees | 3410 | N/A |
| Industry | Precious Metals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.0B |
| IPO Year | N/A | 2000 |
| Metric | DRD | ITGR |
|---|---|---|
| Price | $31.66 | $85.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $32.63 | ★ $91.14 |
| AVG Volume (30 Days) | 308.2K | ★ 623.5K |
| Earning Date | 08-19-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.89 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $36.69 | $1.69 |
| Revenue Next Year | $27.25 | $6.53 |
| P/E Ratio | ★ $15.32 | $30.01 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $13.08 | $62.00 |
| 52 Week High | $39.37 | $127.56 |
| Indicator | DRD | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 54.92 | 48.59 |
| Support Level | $31.59 | $82.58 |
| Resistance Level | $32.61 | $88.54 |
| Average True Range (ATR) | 1.29 | 2.13 |
| MACD | 0.57 | -0.02 |
| Stochastic Oscillator | 81.11 | 29.81 |
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.